Liz Darlison

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

Tom Treasure, Loı̈c Lang-Lazdunski, David Waller et al. · The Lancet Oncology · 2011 · 706 citations · Full text

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

Martin F. Muers, Richard Stephens, P.M. Fisher et al. · The Lancet · 2008 · 257 citations · Full text

Malignant Pleural Mesothelioma, Oncology, Cancer Management +5

Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

Dean A. Fennell, Sean Ewings, Christian H. Ottensmeier et al. · The Lancet Oncology · 2021 · 251 citations · Full text

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Ian Woolhouse, Lesley Bishop, Liz Darlison et al. · Thorax · 2018 · 204 citations · Full text

Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

Dean A. Fennell, Amy King, Seid Mohammed et al. · The Lancet Respiratory Medicine · 2021 · 108 citations

Medicine, Pathology, Immune Checkpoint Inhibitor +5